% latex table generated in R 3.6.1 by xtable 1.8-4 package
% Tue Mar 31 15:16:27 2020
\begin{tabular}{lp{6.5cm}rrp{2.2cm}p{2.2cm}}
  \hline
Group & CCS codes & $n_{out}$ & $n_{obs}$ & \% change in rate below $25 \mu g \cdot m^{-3}$ (95\%CI) & \% change in rate above $25 \mu g \cdot m^{-3}$ (95\%CI) \\ 
  \hline
 1 & Intracranial hemorrhage (7.3.1.1) &  1 & 413,040 & -2.0 (-3.1, -0.9) & -1.4 (-2.3, -0.4) \\ 
   2 & Other aneurysm (7.4.2.2) &  1 & 99,464 & -1.9 (-3.8, 0.1) & -2.5 (-4.2, -0.8) \\ 
   3 & Hypertension with complications and secondary hypertension (7.1.2) &  2 & 452,667 & 0.1 (-0.5, 0.8) & -0.0 (-0.6, 0.6) \\ 
   4 & Essential hypertension (7.1.1) &  1 & 155,533 & 0.2 (-0.5, 0.8) & -0.0 (-0.6, 0.6) \\ 
   5 & Nonspecific chest pain (7.2.5) &  1 & 1,191,085 & 0.2 (-0.2, 0.6) & -0.1 (-0.5, 0.2) \\ 
   6 & Hemorrhoids (7.5.3) &  1 & 76,392 & 0.3 (-0.4, 0.9) & 0.4 (-0.3, 1.0) \\ 
   7 & Other diseases of veins and lymphatics (7.5.4) &  1 & 52,574 & 0.3 (-0.4, 0.9) & 0.3 (-0.3, 1.0) \\ 
   8 & Cardiac arrest and ventricular fibrillation (7.2.10) &  1 & 46,632 & 0.3 (-0.2, 0.8) & 0.1 (-0.4, 0.6) \\ 
   9 & Conduction disorders (7.2.8) &  4 & 261,745 & 0.3 (-0.2, 0.8) & 0.1 (-0.4, 0.5) \\ 
  10 & Varicose veins of lower extremity (7.5.2) &  1 & 10,388 & 0.3 (-0.3, 1.0) & 0.3 (-0.3, 1.0) \\ 
  11 & Pulmonary heart disease (7.2.6) &  1 & 455,764 & 0.3 (-0.1, 0.8) & 0.1 (-0.3, 0.6) \\ 
  12 & Phlebitis; thrombophlebitis and thromboembolism (7.5.1) &  2 & 451,848 & 0.4 (-0.3, 1.0) & 0.3 (-0.3, 0.9) \\ 
  13 & Heart valve disorders (7.2.1) &  4 & 136,654 & 0.4 (-0.1, 0.9) & 0.1 (-0.4, 0.6) \\ 
  14 & Coronary atherosclerosis and other heart disease (7.2.4) &  6 & 1,735,519 & 0.4 (0.2, 0.5) & 0.1 (-0.1, 0.2) \\ 
  15 & Other and ill-defined heart disease (7.2.7) &  1 & 16,972 & 0.4 (-0.1, 0.9) & 0.0 (-0.5, 0.5) \\ 
  16 & Transient cerebral ischemia (7.3.4) &  1 & 753,545 & 0.4 (-0.1, 1.0) & -0.4 (-0.9, 0.1) \\ 
  17 & Peri-; endo-; and myocarditis; cardiomyopathy (except that caused by TB or STD) (7.2.2) &  2 & 118,614 & 0.4 (-0.1, 0.9) & 0.1 (-0.4, 0.6) \\ 
  18 & Aortic; peripheral; and visceral artery aneurysms (7.4.2); abdominal aortic aneurysm; without rupture (7.4.2.1) &  2 & 54,327 & 0.4 (-0.2, 1.1) & 0.1 (-0.5, 0.7) \\ 
  19 & Congestive heart failure; nonhypertensive (7.2.11); congestive heart failure (7.2.11.1) &  2 & 2,268,162 & 0.5 (0.1, 0.8) & 0.4 (0.1, 0.7) \\ 
  20 & Late effects of cerebrovascular disease (7.3.5) &  1 & 30,662 & 0.5 (-0.1, 1.1) & -0.1 (-0.6, 0.5) \\ 
  21 & Other circulatory disease (7.4.4) &  2 & 363,953 & 0.5 (-0.1, 1.1) & 0.2 (-0.4, 0.8) \\ 
  22 & Other and ill-defined cerebrovascular disease (7.3.3) &  1 & 56,907 & 0.6 (-0.0, 1.2) & -0.1 (-0.7, 0.4) \\ 
  23 & Cardiac dysrhythmias (7.2.9) &  7 & 2,205,050 & 0.6 (0.2, 0.9) & -0.2 (-0.5, 0.1) \\ 
  24 & Aortic and peripheral arterial embolism or thrombosis (7.4.3) &  3 & 74,709 & 0.6 (-0.1, 1.2) & 0.1 (-0.5, 0.7) \\ 
  25 & Occlusion or stenosis of precerebral arteries (7.3.2) &  1 & 160,693 & 0.6 (0.0, 1.2) & -0.1 (-0.6, 0.5) \\ 
  26 & Acute myocardial infarction (7.2.3) &  1 & 2,106,507 & 0.7 (0.3, 1.0) & 0.1 (-0.2, 0.5) \\ 
  27 & Occlusion of cerebral arteries (7.3.1.2); acute but ill-defined cerebrovascular accident (7.3.1.3) &  2 & 1,832,455 & 0.7 (0.2, 1.1) & 0.1 (-0.3, 0.5) \\ 
  28 & Peripheral and visceral atherosclerosis (7.4.1) &  3 & 355,348 & 0.7 (0.1, 1.3) & 0.1 (-0.4, 0.7) \\ 
  29 & Heart failure (7.2.11.2) &  1 & 70,084 & 3.6 (1.4, 5.8) & 1.1 (-0.7, 2.9) \\ 
   \hline
\end{tabular}

